Syngeneic Mouse Model
Syngeneic Mouse Model - Related Videos
05:06
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
0 Views •
Cited by 2 •
2015
The metastatic spread of cancer is the major cause of cancer-related deaths. We provide an in-depth description of our survival surgery methodology for establishing a “patient-like” orthotopic syngeneic mouse model system for studying the mechanisms of metastasis in solid organ tumors.
06:20
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
0 Views •
Cited by 4 •
2022
Syngeneic mouse orthotopic allografts of pancreatic ductal adenocarcinoma (PDAC) recapitulate the biology, phenotypes, and therapeutic responses of disease subtypes. Owing to their fast, reproducible tumor progression, they are widely used in preclinical studies. Here, we show common practices to generate these models, injecting syngeneic murine PDAC cultures into the pancreas.
07:46
A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer
0 Views •
2025
A major challenge of developing new therapies for lung cancer includes modeling the tumor microenvironment as regional disease progresses to metastatic disease. Here, we describe a simple method of establishing an orthotopic syngeneic model of lung cancer that allows for in vivo tracking of disease over time.
08:05
A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation
0 Views •
Cited by 11 •
2018
Irreversible electroporation (IRE) is a non-thermal ablation technique used for the treatment of locally advanced pancreatic cancer. Being a relatively new technique, the effects of IRE on the tumor growth are poorly understood. We have developed a syngeneic mouse model that facilitates studying the effects of IRE on pancreatic cancer.
06:38
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
0 Views •
Cited by 23 •
2017
Implementation of an orthotopic model of renal cell carcinoma in immunocompetent mice affords the investigator a clinically-relevant system defined by the presence of a primary renal tumor and lung metastases in the same animal. This system can be used to preclinically test a variety of treatments in vivo.
FAQs
Genetic matching reduces major histocompatibility barriers between transferred cells or tissues and the recipient. This allows the experimental system to retain immune recognition of foreign, diseased, or altered cells without the response being dominated by incompatibility between donor and host. Researchers can therefore examine how immune regulation and inflammation relate to the biological condition under investigation.
An immunocompetent host preserves interactions among pathogens, tissues, and the immune system. Those interactions can influence inflammation, immune regulation, and treatment effects, making the model useful for studying responses that depend on coordinated host defenses. This context helps researchers evaluate infection-control strategies and immune-targeted interventions under conditions that include an intact immune response.
The model supports analysis of host–pathogen interactions alongside tissue responses and immune regulation. Because transferred cells or tissues can be studied without a major genetic compatibility barrier, observed changes can be related more directly to disease, altered-cell behavior, inflammatory responses, or treatment effects. This makes the system valuable when several biological processes influence one another.
The experimental design should align the transferred cells or tissues, the genetically matched recipient, and the biological question being tested. Researchers should also identify whether the study focuses on pathogens, inflammation, immune regulation, diseased or altered cells, or treatment effects. Matching these elements helps ensure that the intact immune environment provides relevant information rather than obscuring the intended comparison.
These models allow investigators to examine vaccine or infection-control effects while pathogens, tissues, and immune responses interact within an immunocompetent host. The resulting observations can address both the effect on infection-related biology and the accompanying host response. This broader view is important when protection or control depends on immune regulation and inflammatory processes.
A syngeneic mouse model can reveal how an immunotherapy affects diseased or altered cells in the presence of an intact immune system. Researchers can assess treatment effects together with immune recognition, inflammation, and regulation rather than examining the intervention in isolation. Such findings help connect therapeutic activity with the host responses that may influence its outcome.